EN | UA
EN | UA

Help Support

Back

Alternate-day low-dose Dutasteride improves prostate health with alpha-blockers

Urinary tract infection/ Benign prostatic enlargement Urinary tract infection/ Benign prostatic enlargement
Urinary tract infection/ Benign prostatic enlargement Urinary tract infection/ Benign prostatic enlargement

What's new?

Alternating day doses of Dutasteride 0.5 mg alleviate sexual dysfunction while maintaining prostate size reduction and voiding improvements, unlike daily dosing.

Posted in ‘Medicine, Baltimore’, a novel prospective study aimed to examine how variable doses of Dutasteride in combination affect patients with Benign Prostatic Enlargement (BPE).

BPE is a commonly observed disease in ageing men which affects about 90% of men in their 80's.

Included in this randomised study were 300 men who had moderate to severe urinary tract infections caused by BPE, and had a prostate volume of more than 40 cc. Three groups comprising 100 members each were administered the combination therapies under:

  • Group I patients were administered Tamsulosin 0.4 mg + Dutasteride 0.5 mg daily
  • Group II patients were administered Tamsulosin 0.4 mg + Dutasteride 0.5 mg every other day
  • Group III patients were given Tamsulosin 0.4 mg + Dutasteride 0.5 mg on a weekly basis

Patients were followed up every 3 months for a year to evaluate the efficacy and safety along with the medication’s effect on prostate size and erectile function.

After one year of treatment, each group experienced a notable improvement in their symptom scores. In terms of prostate size, Group I and II showed signs of prostate reduction but no changes were seen in Group III. After 12 months, Group I showed a substantial shift in sexual dysfunction.

Summing up, alternate-day Dutasteride is as effective as daily dosing for prostate size with better preserves sexual function.

Source:

Medicine, Baltimore

Article:

Effect of dose reduction of Dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement

Authors:

Abou-Farha, Mohamed et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: